Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kundan Iqbal

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Musculoskeletal Disease|December 2, 2015
Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective reviewKundan Iqbal, Clive Kelly
Clinical Therapeutics|June 15, 2019
Potential Pharmacologic Targets for the Prevention of Rheumatoid ArthritisJohn D Isaacs, Kundan Iqbal
Best Practice & Research. Clinical Rheumatology|December 15, 2016
Lung involvement in inflammatory rheumatic diseasesClive Kelly, Kundan Iqbal, La'ali Iman-Gutierrez, et al.
Rheumatology (Oxford, England)|February 13, 2019
Routine musculoskeletal ultrasound findings impact diagnostic decisions maximally in autoantibody-seronegative early arthritis patientsKundan Iqbal, Dennis W Lendrem, Ben Hargreaves, et al.
RMD Open|September 29, 2017
Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologicKatie L Druce, Kundan Iqbal, Kath D Watson, et al.
Rheumatology (Oxford, England)|February 18, 2020
Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasisMd Yuzaiful Md Yusof, Kundan Iqbal, Michael Darby, et al.
Rheumatology (Oxford, England)|November 5, 2020
Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK studyClive A Kelly, Mohamed Nisar, Suba Arthanari, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Musculoskeletal Disease|December 2, 2015
Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective reviewKundan Iqbal, Clive Kelly
Clinical Therapeutics|June 15, 2019
Potential Pharmacologic Targets for the Prevention of Rheumatoid ArthritisJohn D Isaacs, Kundan Iqbal
Best Practice & Research. Clinical Rheumatology|December 15, 2016
Lung involvement in inflammatory rheumatic diseasesClive Kelly, Kundan Iqbal, La'ali Iman-Gutierrez, et al.
Rheumatology (Oxford, England)|February 13, 2019
Routine musculoskeletal ultrasound findings impact diagnostic decisions maximally in autoantibody-seronegative early arthritis patientsKundan Iqbal, Dennis W Lendrem, Ben Hargreaves, et al.
RMD Open|September 29, 2017
Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologicKatie L Druce, Kundan Iqbal, Kath D Watson, et al.
Rheumatology (Oxford, England)|February 18, 2020
Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasisMd Yuzaiful Md Yusof, Kundan Iqbal, Michael Darby, et al.
Rheumatology (Oxford, England)|November 5, 2020
Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK studyClive A Kelly, Mohamed Nisar, Suba Arthanari, et al.
Pageof 1